Factual end-of-day data for BIOCON: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 43,24,350 shares was close to the 20-day average.
BIOCON's delivery share of 40.4% was below its 20-day average of 49.6%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 41,574 shares on the buy side vs 0 on the sell side.
Largest single buy-side trade: 15,451 shares at ₹411.99.
| Indicator | Reading (10 Jul 2026) |
|---|---|
| RSI (14) | 53.2 |
| 50-day EMA | ₹408.32 — close is above |
| 200-day EMA | ₹386.22 — close is above |
| SuperTrend (10, 3) | ₹438.88 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
BIOCON is a large-cap NSE stock in the Pharma sector (Biotechnology industry), with a market capitalisation of about ₹51,581 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.